Abstract
As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected. Catheter-based hepatic arterial procedures may be an option in patients with primary and metastatic liver cancer. The authors describe four catheter-based hepatic arterial procedures and outline the management of potential complications during the immediate postprocedural period.
Copyright © 2015 Cleveland Clinic.
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Carcinoma, Hepatocellular / blood supply
-
Carcinoma, Hepatocellular / therapy*
-
Chemoembolization, Therapeutic*
-
Cisplatin / administration & dosage
-
Doxorubicin / administration & dosage
-
Embolization, Therapeutic*
-
Humans
-
Liver Neoplasms / blood supply
-
Liver Neoplasms / therapy*
-
Mitomycin / administration & dosage
-
Postoperative Care
-
Postoperative Complications
-
Radiotherapy*
-
Yttrium Radioisotopes / therapeutic use*
Substances
-
Antineoplastic Agents
-
Yttrium Radioisotopes
-
Mitomycin
-
Doxorubicin
-
Cisplatin